Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 6/20 | 0.33 |
| ▸ | FNTB | P49356 | 6/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | AGER | Q15109 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | APAF1 | O14727 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21592297 | 1.00 | FNTA (0.33) | FNTAFNTBCYP17A1CYP19A1CYP11B1 | |
| SCHEMBL21592291 | 0.83 | KMT2A (0.35) | CYP17A1CYP19A1CYP11B1CYP11B2TDP1 | |
| SCHEMBL21592282 | 0.75 | CYP11B1 (0.40) | CYP11B1CYP11B2KMT2AMEN1POLB | |
| SCHEMBL21591545 | 0.75 | SMN1; SMN2 (0.33) | TDP1KMT2AMEN1POLBPTPN1 | |
| SCHEMBL21592285 | 0.75 | KCNA5 (0.36) | CYP17A1CYP19A1CYP11B1CYP11B2TDP1 | |
| SCHEMBL21591551 | 0.74 | MEN1 (0.33) | TDP1KMT2AMEN1POLBPTPN1 | |
| SCHEMBL21592298 | 0.74 | KCNA5 (0.36) | CYP11B1CYP11B2ALDH1A1KDM4ENPSR1 | |
| SCHEMBL31361799 | 0.71 | ACHE (0.33) | CYP11B1CYP11B2KMT2AMEN1POLB | |
| SCHEMBL21591562 | 0.71 | ACHE (0.33) | CYP11B1CYP11B2KMT2AMEN1POLB | |
| SCHEMBL21591431 | 0.70 | CYP11B1 (0.48) | CYP17A1CYP19A1CYP11B1CYP11B2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12162863-B2 | Modulators of stimulator of interferon genes (STING) | Ryvu Therapeutics S.A. (PL) | 2024-12-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12162863-B2 | Modulators of stimulator of interferon genes (STING) | STING1, IRF3, CGAS | FNTA 1343/4885FNTB 861/4885CYP17A1 914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.